Industrial Goods » Precision Products | PerkinElmer Inc.

PerkinElmer Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
167,212.00
157,778.00
212,425.00
234,299.00
292,633.00
237,927
Depreciation, Depletion & Amortization
128,471.00
116,736.00
105,364.00
99,972.00
105,000.00
180,588
Other Funds
-
855.00
21,038.00
2,055.00
23,297.00
74,354
Funds from Operations
273,708.00
345,765.00
352,042.00
385,647.00
326,114.00
441,766
Changes in Working Capital
115,117.00
64,168.00
64,944.00
35,032.00
37,661.00
130,728
Net Operating Cash Flow
158,591.00
281,597.00
287,098.00
350,615.00
288,453.00
311,038
Capital Expenditures
38,991.00
29,072.00
28,218.00
31,702.00
39,089.00
Sale of Fixed Assets & Businesses
52,202.00
2,531.00
-
21,000.00
1,100.00
Purchase/Sale of Investments
-
-
59.00
16,959.00
42,976.00
Net Investing Cash Flow
1,211.00
295,897.00
100,856.00
100,843.00
1,249,372.00
Cash Dividends Paid - Total
31,600.00
31,620.00
31,571.00
30,799.00
30,793.00
Issuance/Reduction of Debt, Net
15,475.00
104,480.00
35,072.00
55,226.00
822,156.00
Net Financing Cash Flow
154,160.00
30,931.00
107,139.00
115,011.00
782,236.00
Net Change in Cash
1,798.00
1,579.00
63,111.00
121,333.00
157,131.00
Free Cash Flow
119,600.00
252,525.00
258,880.00
318,913.00
249,364.00
Deferred Taxes & Investment Tax Credit
29,907.00
33,351.00
6,571.00
6,526.00
28,854.00
51,103
Net Assets from Acquisitions
15,699.00
271,477.00
72,040.00
71,924.00
1,527,183.00
Other Sources
1,277.00
2,121.00
757.00
44.00
272,824.00
Change in Capital Stock
107,085.00
41,074.00
61,534.00
137,383.00
14,170.00
Exchange Rate Effect
1,422.00
15,052.00
15,992.00
13,428.00
21,552.00
Other Uses
-
-
1,414.00
1,302.00
-

About PerkinElmer

View Profile
Address
940 Winter Street
Waltham Massachusetts 02451
United States
Employees -
Website http://www.perkinelmer.com
Updated 07/08/2019
PerkinElmer, Inc. (United States) engages in the provision of products, services, and solutions to diagnostics, food, environmental, industrial, life sciences research, and laboratory services markets. It operates through the Discovery and Analytical Solutions, and Diagnostics segments. The Discovery and Analytical Solutions segment comprises of technologies that help life sciences researchers better understand diseases and develop treatments.